Abstract. Selected results are presented and discussed concerning nuclear data relevant to the production of innovative medical radionuclides of special interest, as from research activities brought up at INFN LASA Laboratory, with reference to irradiation experiments at the K = 38 Cyclotron JRC-Ispra Cyclotron Laboratory. Measurements of excitation functions of the involved nuclear reactions are considered, in comparison with corresponding theoretical calculations, especially including radiation detection measurements, through the relevant instruments, and the requested radiochemistry studies. The considered radionuclides and the relevant production reactions are specified in the following introduction, also concerning recent and new measurements.
Introduction
A series of high specific activity accelerator-produced radionuclides in no-carrier-added (NCA) form, for uses in therapeutic applications and in related PET and SPECT diagnoses have been critically investigated and/or fully revisited, including thick target measurements, particularly:
1. NCA 64 Cu, produced by the nat Zn(d,αxn) and nat Zn(d,2pxn) reactions for simultaneous β + /β − metabolic radiotherapy with intrinsic PET imaging, including the short-lived radionuclide 61 Cu, and also 66,67 Ga as highly relevant radionuclides; 2.
186g Re, produced by the 186 W(p,n) reaction for bone metastases pain palliation by negatron (1.1 MeV) metabolic radiotherapy including SPECT imaging; 3. NCA 211 At/ 211g Po, produced by the 209 Bi(α,2n) reaction, with internal spike of gamma emitter 210 At from the 209 Bi(α,3n) reaction (and small amount of 210 Po as radiotoxic long-lived impurity), for high-LET radio-and immuno-radiotherapy; 4. 103 Pd, as a commonly used radionuclide for therapeutic treatments, produced by the alternative 103 Rh(d,2n) reaction route; 5. Studies intended to the production of therapeutic 230 Pa/ 230 U alpha-emitters by the reaction 232 Th(p,3n).
The nuclear data relevant to the excitation functions of the involved nuclear reactions, including the ones concerning the production of radionuclides as contaminants, are discussed through appropriate comparison of present and other available and critically selected experimental values previously published and with model calculations presently done [1] [2] [3] . Particularly in the following, special care is devoted to the discussion of the results for the production of 211 [8] [9] [10] [11] [12] [13] .
For the other radionuclides, main care has been devoted by the authors to critically survey the relevant results, as from the published papers [3] [4] [5] [6] [7] .
Materials and experimental methods
Targets were irradiated at the Scanditronix MC40 cyclotron (K = 38), JRC-Ispra (Varese, Italy) of the EC, that can deliver variable energy proton or alpha beams with energies up to 38 MeV and deuteron beams up to 19 MeV.
Concerning the At radionuclides (RNs), 211 At is clearly the most promising for labelling drugs and radiopharmaceutical compounds for metabolic radionuclide therapy, for the following reasons:
-the half-life of 7.214 h is reasonably sufficient long to label organic compounds, due to the strengths of C-At, O-At and N-At bonds, that are similar to those of iodine; -the 211 At α branching of 41.80%, which is the highest among the "medium-lived" At RNs. Although decaying by EC, the further 58.20% also leads to alpha emission through 211g Po that has an α-branching of 100% and an half-life of 516 ms too short to allow its migration from the location of its formation. As a consequence the "overall" α-branching of the decay of 211 At is 100%; -the energy of the α-particles ranges from 5870 keV to 7450 keV (with an approximated arithmetical average of 6665 keV); -the two main α-particles of the 211 At → 211g Po decay have an average range of 60 to 67 µm in water and soft tissues and a nearly optimal LET ∞ of 100-130 eV · nm −1 , which is around the maximum of the Q-curve for energetic ions.
A good choice for a production method of 211 At has been to minimize isotopic contamination by the Po nuclides to negligible levels. The direct production method based on the nuclear reactions 209 Bi(α,2n) 211 At seems the most satisfactory, because it can be done in a medium energy cyclotron, ©2008 CEA, published by EDP Sciences leading to a high yield and low contamination by the only radionuclidic impurity 210 At, that can be assumed as internal spike, or not produced if the α beam energy is kept less than 28.61 MeV.
The irradiation experiments for 211 At have been carried out at low beam current of alpha particles (50 to 250 nA), with an integrated beam charge of 100 and 450 µC, measured with an error smaller than 1-2% through a Faraday cup connected to a charge integrator. Besides, the reliability of beam charge integrator was checked by thin Cu monitor foils. In order to produce NCA 211 At/ 211g Po for metabolic radiotherapy, a suitable radiochemical separation of At radionuclides from Po by-products and from the Bi target with quality control has been done. The radiochemical separation adopted has been a classical "wet" method based on liquid/liquid extraction.
The γ-, X-spectra have been measured with coaxial HPGe detectors, the α-spectra with Si surface barrier or PIPS detectors, with a resolution of 27 keV (FWHM), and β-spectra with a conventional liquid scintillation counting LSC and spectrometry system with Horrocks number capability and an higher-resolution liquid scintillation portable spectrometer with α/β pulse shape analysis (PSA) discriminator. Significant results from the present measurements and the relevant analysis are shown in the following figures 1-2, concerning gamma-ray and alpha particle spectra referring to the produced radionuclides, including evidence of X-ray emission data for the product 211 At/ 211g Po. The radionuclidic purity of the different radiochemistry fractions produced from Bi target, 210 Po impurities and the final solution were also determined accordingly.
In table 1 the experimental thick target yield TTY obtained at LASA Labs is compared with the calculated one (from 28.8 down to 20 MeV), both from the experimental microscopic data and from model prediction through the EMPIRE II code [15] ; the discrepancies appear to be reasonable with regard to overall uncertainties, including the ones concerning the model parameterisation.
Concerning the production route of 186g Re by (p,n) reaction on 186 Fig. 2 . α-spectrum from Bi irradiated with 32.8 MeV α-particles. These α-spectra are relevant to the radiochemical purity performance of the final products. past months at LASA Labs to deduce measured excitation functions starting from irradiation experiments on nat W at the above mentioned MC40 cyclotron, with proton beam energy ranging from 7 to 15 MeV. In the figure 3 the present results are compared with the previous literature ones and with nuclear model calculated curve obtained through EMPIRE II code [15] . A general comment to figure 3 from our recent results is that our results lie between the previously discrepant experimental data by Szelecsenyi, Shigeta (highest value trend) and Zhang (lowest value trend). The values obtained by the present measurements as from the same figure 3 mostly appear to agree within 3 σ limits with the other quoted measurements. A discrepancy was noted between the γ-intensity value adopted by Zhang (9.20%), our adopted value (8.22% [14] ) and the one adopted by Szelecsenyi (8.5%). The previous measurements of the excitation function for producing 64 Cu have also been revisited, with main concern to gamma spectroscopy and radiation calibration aspects. The results are shown in the figures 4 and 5.
As from the zoom region of the figure 4 the gamma line (α = 0.473% [14] ) for 64 Cu, even if very close to the two lines of 66 Ga, is very well resolved to allow an accurate determination of the 64 Cu activity. The reliability of such measurements is confirmed by the χ 2 -value of the decay curve, obtained from 1346 keV γ-line as shown in figure 5 , then the reliability is reconfirmed of the previously published experimental cross section data [4] [5] [6] . The experimental data from the complete experiment are shown in the figure 6.
Nuclear model calculations concerning the relevant excitation functions
The excitation function calculations have been carried out through the EMPIRE-II code system, by M. Herman [15] , accounting for the major reaction mechanisms for the various competing nuclear reaction channels, including the Optical Model (OM) and the full-featured Hauser-Feshbach model. Special care has been devoted to the model parameterisation, especially concerning the nuclear discrete level structure and the level density approach in the continuum, for both target and residual nuclei. When level density parameters could not be determined from the experiments, as for 186g Re, the BCS approach was assumed. Particularly the Monte Carlo Preequilibrium calculations have been successful in approximating the experimental values, in the case of proton induced reaction presently investigated.
Taking advantage from a long-time experience and activities in the field, the excitation functions were calculated for (α,2n) and (α,3n) reactions on 209 Bi target for the production of 211 At and 210 At, and for 186 W(p,n) reaction and 103 Rh(d,2n) reaction for producing respectively 186g Re and 103 Pd therapeutic radionuclides and for the 232 Th(p,3n) reaction producing 230 Pa/ 230 U therapeutic alpha emitters. Particularly, in the last two cases, the research was aimed to investigate the possible production optimal conditions, relevant to future Cyclotron irradiations experiments by proton and deuteron beams.
Moreover, it is noted that a specific suitable target on which proton irradiation can lead to alpha emitters is thorium, especially through the following reaction: Due to the Q-value of this reaction, it is appropriate to utilize the Ispra accelerator, as it can deliver protons up to 38 MeV, or dedicated 30 MeV cyclotrons. Model calculation by EMPIRE II code have been done for other proton induced reactions on 232 Th (as possible alternatives for therapeutic radionuclide production, as proposed in [13] ) resulting to much lower cross section values, i.e., in the range of few mb. A reasonable agreement between the theoretical results and the existing experimental data is shown in the corresponding figures 3, 7 and 8 of this paper.
General Remarks
Our previous results were partially compared with the ones discussed in the context of IAEA CRP on the nuclear data for therapeutic radionuclide production. Such a comparison gave reason for further investigation as by the present work.
